All Posts

A new drug tested at Sylvester Comprehensive Cancer Center is generating encouraging results for patients with low-grade gliomas.

Mayo Clinic is bringing new hope for patients diagnosed with the most aggressive and treatment-resistant cancers.

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data from the ADVANCE clinical trial.

The pioneering work at Sylvester is bringing hope to patients at a time when melanoma cases are on the rise.

After more than a decade of cancer treatment at UF Health, Dave felt supported every step of the way.

Two new studies seek to understand the disease more fully at the molecular level, with the ultimate aim of developing new treatments.

When an aggressive lymphoma threatened to derail a couple's happily ever after, the Mayo Clinic Comprehensive Cancer Center helped them find a future.

Cancer is never part of the plan, nor is giving up the dream of having children. UF Health’s Oncofertility Program empowers patients with cancer to take control of their future by preserving their fertility.

By bringing together clinicians, patient advocates and researchers across disciplines, the UF Cardio-Oncology Symposium on April 3 provided an engaging forum to spark new research collaborations. The event showcased how innovations in precision medicine, early detection and multidisciplinary collaboration are directly enhancing patient care, ensuring the cancer patient of today does not become the cardiac patient of tomorrow.

Renal cell carcinoma, the most common form of kidney cancer, has some particular metabolic quirks. The cancer accumulates large amounts of lipids inside its cells, giving it a characteristic “clear cell” appearance, almost like little bubbles of water under the microscope.